Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationAnemia, AplasticTransplantation ConditioningLeukemiaTransplantation ChimeraLiver TransplantationGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHematopoietic Stem CellsHistocompatibility TestingHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesMice, Inbred C57BLHematopoiesisKidney TransplantationT-LymphocytesRecurrenceCombined Modality TherapyTime FactorsRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteImmunosuppressive AgentsTreatment OutcomeBone Marrow ExaminationHematologic NeoplasmsGraft RejectionRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressionTransplantation ImmunologyHepatic Veno-Occlusive DiseaseBone RemodelingLeukemia, MyeloidLymphocyte DepletionBone Marrow NeoplasmsAcute DiseaseGraft vs Host ReactionFlow CytometryLeukocytes, MononuclearLymphoma, Non-HodgkinStem Cell TransplantationLeukocyte TransfusionCells, CulturedColony-Forming Units AssayHeart TransplantationLeukocyte CountHLA AntigensSevere Combined ImmunodeficiencyChimeraSurvival AnalysisLymphocytesMyelodysplastic SyndromesRetrospective StudiesSpleenCell DifferentiationMice, Inbred BALB CCyclosporineLymphocyte TransfusionLung TransplantationGranulocyte Colony-Stimulating FactorPeripheral Blood Stem Cell TransplantationHematologic DiseasesBlood CellsAntineoplastic Combined Chemotherapy ProtocolsLymphocyte ActivationActuarial AnalysisBone DensityImmunophenotypingAntigens, CD34Nuclear FamilyCarmustineFollow-Up StudiesPancytopeniaOrgan TransplantationCytomegalovirus InfectionsImmune SystemAntigens, CDSurvival RateCytarabineGraft vs Tumor EffectAntibodies, MonoclonalImmune ToleranceGraft vs Leukemia EffectCell SeparationMelphalanLymphomaMultiple Myeloma